K <sup>+</sup> Channels as Therapeutic Targets in Oncology
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abdul M , HooseinN. Voltage-gated potassium ion channels in colon cancer.Oncol. Rep.9(5), 961–964 (2002).
Suzuki T , TakimotoK. Selective expression of hERG and Kv2 channels influences proliferation of uterine cancer cells. Int. J. Oncol.25(1), 153–159 (2004).
Abdul M , SantoA, HooseinN. Activity of potassium channel-blockers in breast cancer.Anticancer Res.23(4), 3347–3351 (2003).
Bianchi L , WibleB, ArcangeliAet al. hERG encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res. 58(4), 815–822 (1998).
Roy J , VantolB, CowleyEA, BlayJ, LinsdellP. Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line mcf-7. Oncol Rep.19(6), 1511–1516 (2008).
Wang H , ZhangY, CaoLet al. hERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res. 62(17), 4843–4848 (2002).
Murata H , TajimaN, NagashimaYet al. Von hippel-lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells. Cancer Res. 62(23), 7004–7011 (2002).
Ouadid-Ahidouch H , Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: Possible involvement of a human-ether-a-go-go K+ channel. Receptors Channels7(5), 345–356 (2001).
Weber C , Mello De Queiroz F, Downie B, Sukow A, Stühmer W, Pardo LA. Silencing the activity and proliferative properties of the human Eag1 potassium channel by RNAi. J. Biol. Chem.281, 13033–13037 (2006).
Nilius B , SchwarzG, DroogmansG. Control of intracellular calcium by membrane potential in human melanoma cells.Am. J. Physiol.265(6, 1), C1501–1510 (1993).
Zhou Q , KwanHY, ChanHC, JiangJL, TamSC, YaoX. Blockage of voltage-gated K+ channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int. J. Mol. Med.11(2), 261–266 (2003).